tangeretin has been researched along with swainsonine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandanearatachi, A; Pilkington, GJ; Rooprai, HK; Rucklidge, G | 1 |
| Christidou, M; Dexter, DT; Kandanearatchi, A; Maidment, SL; Pilkington, GJ; Rooprai, HK; Rucklidge, GJ; Trillo-Pazos, G; Widmer, W | 1 |
2 other study(ies) available for tangeretin and swainsonine
| Article | Year |
|---|---|
Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro.
Topics: Antineoplastic Agents; Brain Neoplasms; Captopril; Collagenases; Flavones; Flavonoids; Gelatinases; Glioma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Neoplasm Invasiveness; Swainsonine; Tumor Cells, Cultured | 1999 |
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Captopril; Cell Adhesion; Cell Movement; Cell Survival; Collagen; Drug Evaluation, Preclinical; Ependymoma; Flavones; Flavonoids; Glioblastoma; Humans; Inhibitory Concentration 50; Matrix Metalloproteinases; Neoplasm Invasiveness; Swainsonine; Tumor Cells, Cultured | 2001 |